Third World Must Not Be Deprived Of The Most Advanced Medical Treatments Against AIDS, UNESCO Director-General Declares

November 18, 1997

Paris, November 17 - "It would be a scandal to allow AIDS patients in developing countries to die because they are excluded from receiving the newest therapies," the Director-General of UNESCO, Federico Mayor, declared today.

Mr. Mayor recently attended a co-ordination meeting of agency heads for the Joint United Nations Programme on AIDS (UNAIDS), where he warned the international community against accepting such discrimination against developing countries and urged concrete emergency measures to assist them in their struggle against AIDS.

Here is Mr Mayor's full declaration:

"With the new therapies against AIDS - although we cannot yet assess their long-term efficiency - a great hope was born. These treatments, however, are very expensive and require costly infrastructure for the proper care of patients. The majority of people contaminated by the HIV virus - over 90% - live in developing countries and do not have access to these treatments. It would be their fate to be left, resigned, in their villages or in hospitals, without resources. This would be unacceptable, immoral and outrageous.

"In the face of disease, there must be no discrimination, be it based on nationality or skin colour. All - rich and poor - must be treated equally. We must spend less on the defence of borders which are today little threatened and invest more in the defence of citizens and human dignity.

"It would be a scandal to let patients in developing countries die of AIDS, depriving them of the hope provided by the new therapies. It would be a scandal to accept a de facto disparity in access to treatment to the detriment of Africa, Asia and Latin America. It would be a scandal to close our eyes - due to financial expedience, because of indifference, egocentricity or ignorance - to the slaughter ahead. Moreover, this blindness could have a dangerous boomerang effect : the likelihood of mutant and resistant HIV viruses emerging is proportional to the number of sick people.

"Ahead of World AIDS Day, marked on December 1 with an equal share of hope and despair, I launch an appeal to the international community: let us prevent this scandal from taking place.

"In the name of the intellectual and moral solidarity which is at the heart of UNESCO's mandate, I ask that measures be taken to equip and train medical and scientific personnel in the worst-hit countries to care for their patients. I also ask that measures be taken to reinforce research and work, with the support of the pharmaceutical sector, and the scientific and medical communities, on the development of a vaccine. Massive means must be raised to come to the succour of those who need it most, in keeping with the commitment made at the Denver G-8 Summit. All must also be done, on the national level, with parliamentarians and the media to increase radically the resources for research and treatment of the HIV-positive.

"I salute the initiative launched by the UNAIDS programme to the benefit of several developing countries to improve access for all to the most recent treatments.

"UNESCO is prepared to work with the relevant authorities of the international community and all potential partners to explore ways to provide access to the new therapies to the greatest numbers. Our ethical mission demands that we do all to ensure an equal chance of survival to all."



Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to